1. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Systemic treatment of HER2‐positive metastatic breast cancer: A systematic review. (June 2014) Authors: Wilcken, Nicholas; Zdenkowski, Nicholas; White, Michelle; Snyder, Ray; Pittman, Ken; Mainwaring, Paul; Green, Michael; Francis, Prudence; De Boer, Richard; Colosimo, Maree; Chua, Sue; Chirgwin, Jacquie; Beith, Jane; Bell, Richard Journal: Asia-Pacific journal of clinical oncology Issue: Volume 10(2014)Supplement 4 Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives. (June 2014) Authors: De Boer, Richard; Beith, Jane; Chirgwin, Jacquie; Chua, Sue; Colosimo, Maree; Francis, Prudence; Green, Michael; Pittman, Ken; White, Michelle; Wilcken, Nicholas; Zdenkowski, Nicholas; Bell, Richard Journal: Asia-Pacific journal of clinical oncology Issue: Volume 10(2014)Supplement 4 Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗